Related Experiment Video
Updated: Jul 19, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis
Zhefu Ma1, Shannon L Gibson, Maura A Byrne
1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Abstract:
The insulin receptor substrate (IRS) proteins are cytoplasmic adaptors that organize signaling complexes downstream of activated cell surface receptors. Here, we show that IRS-1 and IRS-2, despite significant homology, play critical yet distinct functions in breast cancer, and we identify specific signaling pathways that are influenced by IRS-1 using the polyoma virus middle-T (PyV-MT) transgenic mouse model of mammary carcinoma and Irs-1 null (Irs1(-/-)) mice. The absence of Irs-1 expression enhanced metastatic spread significantly without a significant effect on primary tumor growth. Orthotopic transplant studies revealed that the increased metastatic potential of Irs1-deficient tumor cells is cell autonomous. Mammary tumors that developed in PyV-MT::Irs1(-/-) mice exhibited elevated Irs-2 function and enhanced phosphatidylinositol 3-kinase/Akt/mTor activity, suggesting that one mechanism by which Irs-1 impedes metastasis is to suppress Irs-2-dependent signaling. In support of this mechanism, reduction of Irs-2 expression in Irs1(-/-) tumor cells restored mTor signaling to wild-type levels. PyV-MT::Irs1(-/-) tumors also exhibited a significant increase in vascular endothelial growth factor expression and microvessel density, which could facilitate their dissemination. The significance of our findings for human breast cancer is heightened by our observation that Irs-1 is inactivated in wild-type, metastatic mammary tumors by serine phosphorylation. Collectively, our findings reveal that inactivation of IRS-1 enhances breast cancer metastasis and support the novel hypothesis that IRS-1 has metastasis suppressor functions for breast cancer.
Insights
Insulin receptor substrate-1 (IRS-1) normally suppresses breast cancer metastasis. Its inactivation enhances metastasis by promoting IRS-2 signaling and tumor vascularization, highlighting IRS-1
Area of Science:
- Molecular biology
- Cancer research
- Cell signaling
Background:
- Insulin receptor substrate (IRS) proteins act as crucial cytoplasmic adaptors in cell signaling pathways.
- IRS-1 and IRS-2 exhibit distinct roles in breast cancer progression.
Purpose of the Study:
- To investigate the distinct functions of IRS-1 and IRS-2 in breast cancer.
- To identify signaling pathways influenced by IRS-1 in mammary carcinoma.
Main Methods:
- Utilized the polyoma virus middle-T (PyV-MT) transgenic mouse model of mammary carcinoma.
- Employed Irs-1 null (Irs1(-/-)) mice and orthotopic transplant studies.
- Analyzed phosphatidylinositol 3-kinase/Akt/mTor signaling and vascular endothelial growth factor expression.
Main Results:
- Absence of IRS-1 significantly enhanced metastatic spread without affecting primary tumor growth.
- Irs1-deficient tumors showed elevated IRS-2 function and phosphatidylinositol 3-kinase/Akt/mTor activity.
- IRS-1 inactivation in tumors increased vascular endothelial growth factor expression and microvessel density, facilitating dissemination.
- IRS-1 is inactivated by serine phosphorylation in human metastatic mammary tumors.
Conclusions:
- IRS-1 functions as a metastasis suppressor in breast cancer.
- Inactivation of IRS-1 promotes breast cancer metastasis through enhanced IRS-2-dependent signaling and increased tumor vascularization.
- Targeting IRS-1 or IRS-2 pathways may offer therapeutic strategies for preventing breast cancer metastasis.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Insulin: The Receptor and Signaling Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of the Unfolded Protein Response
Abnormal Proliferation
